Spanu Pennestri, Teresa
 Distribuzione geografica
Continente #
NA - Nord America 8.567
EU - Europa 7.833
AS - Asia 6.252
SA - Sud America 1.203
AF - Africa 160
OC - Oceania 35
Continente sconosciuto - Info sul continente non disponibili 10
Totale 24.060
Nazione #
US - Stati Uniti d'America 8.348
DE - Germania 3.278
SG - Singapore 2.492
CN - Cina 2.106
BR - Brasile 982
IT - Italia 883
SE - Svezia 857
FR - Francia 555
VN - Vietnam 480
UA - Ucraina 478
PL - Polonia 468
GB - Regno Unito 378
IE - Irlanda 252
IN - India 216
FI - Finlandia 179
ID - Indonesia 171
RU - Federazione Russa 140
TR - Turchia 135
BD - Bangladesh 124
CA - Canada 113
HK - Hong Kong 98
JP - Giappone 98
AR - Argentina 78
AT - Austria 71
IQ - Iraq 53
MX - Messico 52
BE - Belgio 49
NL - Olanda 45
ES - Italia 44
ZA - Sudafrica 40
EC - Ecuador 38
PK - Pakistan 34
IR - Iran 31
SA - Arabia Saudita 30
MA - Marocco 29
PH - Filippine 29
AU - Australia 28
VE - Venezuela 26
CH - Svizzera 24
CL - Cile 20
CO - Colombia 19
KR - Corea 19
CZ - Repubblica Ceca 17
AE - Emirati Arabi Uniti 15
LT - Lituania 15
UZ - Uzbekistan 15
EG - Egitto 14
MY - Malesia 13
PT - Portogallo 13
KE - Kenya 12
PY - Paraguay 12
JM - Giamaica 11
UY - Uruguay 11
CI - Costa d'Avorio 10
DZ - Algeria 10
KZ - Kazakistan 10
PE - Perù 10
TN - Tunisia 10
JO - Giordania 9
MT - Malta 9
NP - Nepal 9
DO - Repubblica Dominicana 8
VA - Santa Sede (Città del Vaticano) 8
BG - Bulgaria 7
EU - Europa 7
GR - Grecia 7
LV - Lettonia 7
NG - Nigeria 7
TW - Taiwan 7
AZ - Azerbaigian 6
ET - Etiopia 6
HU - Ungheria 6
IL - Israele 6
NZ - Nuova Zelanda 6
OM - Oman 6
RS - Serbia 6
SD - Sudan 6
TT - Trinidad e Tobago 6
BO - Bolivia 5
CR - Costa Rica 5
CY - Cipro 5
DK - Danimarca 5
HN - Honduras 5
PA - Panama 5
EE - Estonia 4
GE - Georgia 4
LK - Sri Lanka 4
PS - Palestinian Territory 4
RO - Romania 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
AL - Albania 3
AM - Armenia 3
KG - Kirghizistan 3
LB - Libano 3
LU - Lussemburgo 3
NI - Nicaragua 3
TH - Thailandia 3
TZ - Tanzania 3
A2 - ???statistics.table.value.countryCode.A2??? 2
Totale 24.011
Città #
Singapore 1.326
Chandler 1.063
Ashburn 980
San Jose 628
Hangzhou 609
Warsaw 394
Jacksonville 349
Beijing 332
Ann Arbor 254
San Mateo 250
Dublin 244
New York 236
Nürnberg 223
Nanjing 214
Woodbridge 213
Wilmington 198
Los Angeles 175
Fairfield 174
Dearborn 173
Ho Chi Minh City 158
Jakarta 153
Seattle 150
Houston 143
Lauterbourg 133
Rome 126
The Dalles 121
Hanoi 115
Milan 112
Munich 111
Boston 110
Hefei 106
São Paulo 105
Chicago 100
Izmir 99
Hong Kong 87
Moscow 86
Frankfurt am Main 85
Tokyo 84
Marseille 80
Lawrence 79
Cattolica 78
Buffalo 77
Dallas 76
Nanchang 72
Redwood City 60
Princeton 58
Helsinki 57
Santa Clara 57
Cambridge 53
Kraków 51
Council Bluffs 50
Kunming 47
Vienna 46
Brussels 45
Boardman 43
Bremen 42
Guangzhou 42
Shenyang 41
North Bergen 37
London 36
Tianjin 36
Mountain View 35
Toronto 35
Rio de Janeiro 32
Da Nang 30
Denver 30
Montreal 30
Brooklyn 29
Hebei 29
Nuremberg 29
Changsha 28
Haiphong 28
Paris 28
Zhengzhou 28
Chennai 27
Jiaxing 27
Lancaster 27
Orem 27
Norwalk 26
Shanghai 26
Baghdad 24
Phoenix 24
Redmond 24
San Francisco 24
Atlanta 23
Belo Horizonte 23
Kent 23
Falls Church 22
Fremont 22
Stockholm 22
Johannesburg 21
Augusta 20
Dhaka 19
Leawood 18
Campinas 17
Mexico City 17
Turku 17
University Park 17
Pune 16
Quito 16
Totale 12.442
Nome #
Intestinal parasites isolated in a large teaching hospital, Italy, 1 May 2006 to 31 December 2008 486
Educational interventions alone and combined with port protector reduce the rate of central venous catheter infection and colonization in respiratory semi-intensive care unit. 441
Factors associated with mortality in bacteremic patients with hematologic malignancies. 375
Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy 357
Factors associated with mortality in bacteremic patients with haematologic malignancies 356
Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients 355
In vitro Evaluation of BACT/ALERT® VIRTUO®, BACT/ALERT 3D®, and BACTEC™ FX Automated Blood Culture Systems for Detection of Microbial Pathogens Using Simulated Human Blood Samples 340
Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy 311
Diabetic foot infections: a comprehensive overview 311
Antifungal Susceptibility Profiles of Bloodstream Yeast Isolates by Sensititre YeastOne: a Nine-Year Experience at a Large Italian Teaching Hospital 294
A rapid diagnostic workflow for cefotaxime-resistant Escherichia coli and Klebsiella pneumoniae detection from blood cultures by MALDI-TOF mass spectrometry 286
Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment. 280
Empyema caused by Prevotella bivia complicating an unusual case of spontaneous chylothorax. 278
Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia. 264
Optimized Use of the MALDI BioTyper System and FilmArray BCID Panel for the Direct Identification of Microbial Pathogens from Positive Blood Cultures 250
Performance of two resin-containing blood culture media in detection of bloodstream infections and in direct matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) broth assays for isolate identification: clinical comparison of the BacT/Alert Plus and Bactec Plus systems 248
Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy 239
Application of MALDI-TOF mass spectrometry in clinical diagnostic microbiology 239
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy. 231
Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection 225
Antimicrobial susceptibility testing of pathogens isolated from blood culture: a performance comparison of Accelerate Pheno (TM) and VITEK (R) 2 systems with the broth microdilution method 221
Factors associated with mortality in bacteremic patients with hematologic malignancies. 218
Identifying patients harboring extended-spectrum-beta-lactamase-producing Enterobacteriaceae on hospital admission: derivation and validation of a scoring system. 215
Antibiotic usage and risk of colonization and infection with antibiotic-resistant bacteria: a hospital population-based study 210
Performance of two resin-containing blood culture media in detection of bloodstream infections and in direct matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) broth assays for isolate identification: clinical comparison of the BacT/Alert Plus and Bactec Plus systems 209
Development of a Multiplex PCR Platform for the Rapid Detection of Bacteria, Antibiotic Resistance, and Candida in Human Blood Samples 204
Comparison of Mycoplasma IES, Mycofast Revolution and Mycoplasma IST2 to detect genital mycoplasmas in clinical samples. 204
In Vivo Emergence of Tigecycline Resistance in Multidrug-Resistant Klebsiella pneumoniae and Escherichia coli 203
High-dose daptomycin for cardiac implantable electronic device-related infective endocarditis caused by staphylococcal small-colony variants 198
Carbapenemase-producing Klebsiella pneumoniae and hematologic malignancies 197
Vancomycin versus cefazolin prophylaxis for cerebrospinal shunt placement in a hospital with a high prevalence of meticillin-resistant Staphylococcus aureus 195
Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy. 195
Pertussis in infants less than 6 months of age and household contacts, Italy April 2014 194
Predictive models for identification of hospitalized patients harboring KPC-producing Klebsiella pneumoniae 189
Direct use of eazyplex® SuperBug CRE assay from positive blood cultures in conjunction with inpatient infectious disease consulting for timely appropriate antimicrobial therapy in Escherichia coli and Klebsiella pneumoniae bloodstream infections 189
Diagnosis and Treatment of Bacterial Pneumonia in Critically Ill Patients with COVID-19 Using a Multiplex PCR Assay: A Large Italian Hospital’s Five-Month Experience 189
Clinical and microbiological outcome in septic patients with extremely low 25-hydroxyvitamin D levels at initiation of critical care 187
Efficient Recovery of Candida auris and Five Other Medically Important Candida Species from Blood Cultures Containing Clinically Relevant Concentrations of Antifungal Agents 186
Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy 184
Characteristics of staphylococcus aureus bacteraemia and predictors of early and late mortality 184
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 183
Antifungal susceptibility profiles of bloodstream yeast isolates by Sensititre YeastOne over nine years at a large Italian teaching hospital 181
Characterisation and risk-factor profiling of P. aeruginosa urinary tract infections: pinpointing those likely to be caused by multidrug-resistant strains 181
Risk factors and predictors of mortality of methicillin-resistant Staphylococcus aureus (MRSA) bacteremia in HIV-infected patients 180
High dose tigecycline in critically ill patients with severe infections due to multidrug-resistant bacteria 175
Bacterial bloodstream infections in liver transplantation: etiologic agents and antimicrobial susceptibility profiles 174
A) High levels of dual resistance to clarithromycin and metronidazole and in vitro activity of levofloxacin against Helicobacter pylori isolates from patients after failure of therapy. 171
Direct MALDI-TOF MS Testing from Positive Blood Cultures for Rapid Identification of Bloodstream Infection-Causing Anaerobic Bacteria 168
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy 166
Tsukamurella tyrosinosolvens and Rhizobium radiobacter sepsis presenting with septic pulmonary emboli 166
Simulated Pediatric Blood Cultures to Assess the Inactivation of Clinically Relevant Antimicrobial Drug Concentrations in Resin-Containing Bottles 166
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 165
FETR-ALS Study Protocol: A Randomized Clinical Trial of Fecal Microbiota Transplantation in Amyotrophic Lateral Sclerosis 163
Global climate change and wound care: case study of an off-season vibrio alginolyticus infection in a healthy man 161
Early assessment of blood culture negativity as a potential support tool for antimicrobial stewardship 160
. Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies. 160
Linezolid plasma and intrapulmonary concentrations in critically ill obese patients with ventilator-associated pneumonia: intermittent vs continuous administration 160
Multidrug-resistant Proteus mirabilis bloodstream infections: risk factors and outcomes 159
T2Bacteria magnetic resonance assay for the rapid detection of ESKAPEc pathogens directly in whole blood 159
Trimethoprim-sulfamethoxazole therapy for patients with carbapenemase-producing Klebsiella pneumoniae infections: retrospective single-center case series 157
Bloodstream infections caused by extended -spectrum-beta-lactamase-producing Klebsiella pneumoniae: risk factors, molecular epidemiology, and clinical outcome 156
Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality. 155
Prediction models to identify hospitalized patients at risk of being colonized or infected with multidrug-resistant Acinetobacter baumannii calcoaceticus complex. 155
Evaluation of the new VITEK 2 extended-spectrum beta-lactamase (ESBL) test for rapid detection of ESBL production in Enterobacteriaceae isolates 155
Catheter-related bacteremia by Cupriavidus metallidurans 155
Multidrug-Resistant Proteus mirabilis Bloodstream Infections: Risk Factors and Outcomes 153
Efficacy of Ceftazidime-avibactam Salvage Therapy in Patients with Infections Caused by KPC-producing Klebsiella pneumoniae 153
Comparing BioFire FilmArray BCID2 and BCID panels for direct detection of bacterial pathogens and antimicrobial resistance genes from positive blood cultures 153
Carbapenemase-producingKlebsiella pneumoniaeand Hematologic Malignancies 152
Global climate change and wound care: case study of an off-season vibrio alginolyticus infection in a healthy man. 151
Derivation and validation of a scoring system to identify patients with bacteremia and hematological malignancies at higher risk for mortality 150
Glycopeptide resistance among coagulase-negative staphylococci that cause bacteremia: epidemiological and clinical findings from a case-control study 149
Derivation and Validation of a Scoring System to Identify Patients with Bacteremia and Hematological Malignancies at Higher Risk for Mortality 149
Compliance of clinical microbiology laboratories with recommendations for the diagnosis of bloodstream infections 149
Evaluation of the New NucliSENS EasyQ KPC test for rapid detection of Klebsiella pneumoniae carbapenemase genes (blaKPC) 148
Assessment of linezolid resistance mechanisms among Staphylococcus epidermidis causing bacteraemia in Rome, Italy 144
A 72-h intervention for improvement of the rate of optimal antibiotic therapy in patients with bloodstream infections 143
Direct maldi-tof mass spectrometry assay of blood culture broths for rapid identification of Candida species causing bloodstream infections: an observational study in two large microbiology laboratories 142
Intraventricular versus intravenous colistin for the treatment of extensively drug resistant Acinetobacter baumannii meningitis 142
Risk factors for mortality and cost implications of complicated intra-abdominal infections in critically ill patients 142
Risk Factors for Mortality in Adult COVID-19 Patients Who Develop Bloodstream Infections Mostly Caused by Antimicrobial-Resistant Organisms: Analysis at a Large Teaching Hospital in Italy 140
Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality 138
Lice, rodents, and many hopes: a rare disease in a young refugee 138
EUCAST rapid antimicrobial susceptibility testing of blood cultures positive for Escherichia coli or Klebsiella pneumoniae: experience of three laboratories in Italy 137
Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study 136
Incidence and antimicrobial resistance trends in bloodstream infections caused by ESKAPE and Escherichia coli at a large teaching hospital in Rome, a 9-year analysis (2007–2015) 136
Simplified Testing Method for Direct Detection of Carbapenemase-Producing Organisms from Positive Blood Cultures Using the NG-Test Carba 5 Assay 136
Resource-saving advice from an infectious diseases specialist team in a large university hospital: an exportable model? 135
Clinical impact of pulmonary sampling site in the diagnosis of ventilator-associated pneumonia: A prospective study using bronchoscopic bronchoalveolar lavage 135
Molecular identification of Leuconostoc mesenteroides as a cause of brain abscess in an immunocompromised patient 134
Evaluation of the new VITEK 2 extended-spectrum beta-lactamase (ESBL) test for rapid detection of ESBL production in Enterobacteriaceae isolates. 132
Global climate change and wound care: case study of an off-season vibrio alginolyticus infection in a healthy man 132
Reply to Seligman 131
Characterization of clinical isolates of Enterobacteriaceae from Italy by the BD Phoenix extended-spectrum beta-lactamase detection method 131
HIV-associated bacteremia: how it has changed in the highly active antiretroviral therapy (HAART) era 130
Implementation of the eazyplex(®) CSF direct panel assay for rapid laboratory diagnosis of bacterial meningitis: 32-month experience at a tertiary care university hospital 130
High-dose daptomycin for cardiac implantable electronic device-related infective endocarditis caused by staphylococcal small-colony variants 129
Linezolid plasma and intrapulmonary concentrations in critically ill obese patients with ventilator-associated pneumonia: intermittent vs continuous administration 129
Evaluation of the New NucliSENS EasyQ KPC Test for Rapid Detection of Klebsiella pneumoniae Carbapenemase Gene (blaKPC) 128
Ventriculitis due to Staphylococcus lugdunensis: two case reports 127
Totale 19.152
Categoria #
all - tutte 85.744
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 85.744


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.345 108 111 44 79 67 82 44 235 59 82 210 224
2022/20233.024 364 412 203 425 198 336 149 273 380 93 124 67
2023/20241.353 84 349 39 83 64 197 86 77 15 60 127 172
2024/20252.656 73 75 208 89 239 73 90 117 428 244 543 477
2025/20267.246 1.055 223 469 937 1.314 348 1.195 342 471 446 249 197
2026/2027111 111 0 0 0 0 0 0 0 0 0 0 0
Totale 24.283